Zevra Therapeutics, Inc. Stock Forecast
Green day on Thursday for Zevra Therapeutics, Inc. stock after gaining 3.26%
(Updated on May 02, 2024)
The Zevra Therapeutics, Inc. stock price gained 3.26% on the last trading day (Thursday, 2nd May 2024), rising from $4.60 to $4.75. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.60% from a day low at $4.61 to a day high of $4.78. The price has risen in 7 of the last 10 days and is up by 5.56% over the past 2 weeks. Volume fell on the last day by -37 thousand shares and in total, 123 thousand shares were bought and sold for approximately $582.84 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -30.16% during the next 3 months and, with a 90% probability hold a price between $2.87 and $3.79 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ZVRA Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 5.56%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Zevra Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.10. On a fall, the stock will find some support from the short-term average at $4.58. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Zevra Therapeutics, Inc. stock
Zevra Therapeutics, Inc. finds support from accumulated volume at $4.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.166 between high and low, or 3.60%. For the last week the stock has had daily average volatility of 3.15%.
Our recommended stop-loss: $4.54 (-4.47%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 10 days ago.)
Trading Expectations (ZVRA) For The Upcoming Trading Day Of Friday 3rd
For the upcoming trading day on Friday, 3rd we expect Zevra Therapeutics, Inc. to open at $4.71, and during the day (based on 14 day Average True Range), to move between $4.54 and $4.96, which gives a possible trading interval of +/-$0.206 (+/-4.33%) up or down from last closing price. If Zevra Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.66% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $4.58 (3.58%) than the resistance at $5.03 (5.89%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Zevra Therapeutics, Inc. will release earnings BMO on Wednesday, May 08, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.490. We will update the financials statements for Zevra Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.91% in the first trading day after earnings release.
Is Zevra Therapeutics, Inc. stock A Buy?
Zevra Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: 0.053 Hold/Accumulate Unchanged
Predicted Opening Price for Zevra Therapeutics, Inc. of Friday, May 3, 2024
| Fair opening price May 3, 2024 | Current price |
|---|---|
| $4.71 ( 0.747%) | $4.75 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ZVRA
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 4.88 | 2.75 % | |
| R2 | 4.82 | 1.42 % | ||
| R1 | 4.78 | 0.590 % | ||
| Current price: | 4.75 | |||
| Support | S1 | 4.65 | -2.08 % | |
| S2 | 4.61 | -2.91 % | ||
| S3 | 4.55 | -4.25 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 5.76 | 21.26 % | |
| R2 | 5.16 | 8.63 % | ||
| R1 | 5.03 | 5.89 % | ||
| Current price | 4.75 | |||
| Support | S1 | 4.58 | -3.58% | |
| S2 | 4.52 | -4.84% | ||
| S3 | 4.50 | -5.26% |
FAQ
Click here for our free guide on how to buy Zevra Therapeutics, Inc. Stock.
